*Corresponding Author E-mail: n.sabir@mu.edu.sa
The escalating problem of antimicrobial resistance necessitates the exploration of new strategies to combat microbial infections. This paper investigates emerging antimicrobial approaches, including the discovery of new antibiotics, the development of antimicrobial peptides, and the application of bacteriophage therapy. We also examine the innovative use of nanotechnology and CRISPR-Cas systems in addressing resistant bacterial strains. The mechanisms by which bacteria develop resistance, such as genetic mutations, horizontal gene transfer, and biofilm formation, are analyzed. Through case studies, we illustrate the practical applications and efficacy of these novel strategies in both healthcare and environmental contexts. Addi- tionally, we discuss the challenges in bringing these innovations to widespread use and emphasize the need for ongoing research. Advancing our understanding and development of antimicrobial strategies is vital for outpacing resistance mechanisms and ensuring effective treatments for bacterial infections.
Antimicrobial resistance, Novel antibiotics, Bacteriophage therapy, Nanotechnology in antimicrobial treatment, CRISPR-Cas systems